Chemed Corporation $CHE Position Lowered by Kestra Investment Management LLC

Kestra Investment Management LLC cut its stake in shares of Chemed Corporation (NYSE:CHE) by 43.0% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,827 shares of the company’s stock after selling 1,379 shares during the period. Kestra Investment Management LLC’s holdings in Chemed were worth $923,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Richardson Financial Services Inc. lifted its position in Chemed by 5,700.0% in the 3rd quarter. Richardson Financial Services Inc. now owns 58 shares of the company’s stock worth $29,000 after buying an additional 57 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of Chemed during the 2nd quarter valued at $34,000. Versant Capital Management Inc grew its holdings in shares of Chemed by 7,500.0% during the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after acquiring an additional 75 shares in the last quarter. Keating Financial Advisory Services Inc. purchased a new position in shares of Chemed during the 2nd quarter valued at $36,000. Finally, Fulcrum Asset Management LLP grew its holdings in shares of Chemed by 121.9% during the 3rd quarter. Fulcrum Asset Management LLP now owns 71 shares of the company’s stock valued at $36,000 after acquiring an additional 39 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Price Performance

Shares of CHE opened at $544.82 on Wednesday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.08 and a current ratio of 1.11. The firm has a market cap of $7.09 billion, a PE ratio of 23.49, a PEG ratio of 2.04 and a beta of 0.50. The firm’s 50 day moving average price is $515.29 and its 200 day moving average price is $466.00. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $562.24.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, October 27th. The company reported $6.75 EPS for the quarter, topping the consensus estimate of $6.44 by $0.31. Chemed had a net margin of 10.61% and a return on equity of 35.18%. The company had revenue of $690.94 million during the quarter, compared to the consensus estimate of $685.04 million. During the same period in the previous year, the firm posted $5.27 earnings per share. The company’s revenue for the quarter was up 10.6% compared to the same quarter last year. As a group, research analysts expect that Chemed Corporation will post 24.05 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 4th. Investors of record on Monday, November 16th will be paid a $0.70 dividend. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, November 16th. Chemed’s payout ratio is presently 13.40%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Wall Street Zen upgraded Chemed from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 10th. UBS Group lifted their price objective on Chemed from $650.00 to $675.00 and gave the company a “buy” rating in a research report on Thursday, October 29th. Jefferies Financial Group upgraded Chemed from a “hold” rating to a “buy” rating and boosted their target price for the company from $520.00 to $620.00 in a research note on Wednesday, October 28th. Weiss Ratings raised Chemed from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Finally, Royal Bank Of Canada upped their target price on Chemed from $548.00 to $585.00 and gave the stock a “sector perform” rating in a research report on Thursday, October 29th. Three investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $603.00.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Tuesday, November 3rd. The shares were sold at an average price of $537.90, for a total transaction of $1,075,800.00. Following the transaction, the chief executive officer directly owned 82,220 shares of the company’s stock, valued at $44,226,138. This represents a 2.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Spencer S. Lee sold 920 shares of the stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $537.17, for a total transaction of $494,196.40. Following the transaction, the executive vice president directly owned 13,931 shares in the company, valued at $7,483,315.27. The trade was a 6.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 9,920 shares of company stock valued at $5,223,056. 3.33% of the stock is owned by company insiders.

Chemed Company Profile

Chemed Corporation is a U.S.-based company operating through two principal businesses: VITAS Healthcare, which provides hospice and palliative care, and Roto-Rooter, which offers plumbing, drain-cleaning and water-restoration services. VITAS serves patients with serious illnesses through home-based care and services in hospice facilities and other care settings. Roto-Rooter serves residential and commercial customers with plumbing and drain services, as well as cleanup and restoration following water damage.